4.6 Article

The Antimicrobial Peptide Esc(1-21) Synergizes with Colistin in Inhibiting the Growth and in Killing Multidrug Resistant Acinetobacter baumannii Strains

期刊

ANTIBIOTICS-BASEL
卷 11, 期 2, 页码 -

出版社

MDPI
DOI: 10.3390/antibiotics11020234

关键词

antibiotic resistance; Acinetobacter baumannii; antimicrobial peptides; colistin; synergy; membrane perturbation

资金

  1. Sapienza University of Rome [RM11916B6A28725C]
  2. Pasteur-Italia Fondazione Cenci Bolognetti
  3. Ateneo Funds [RM11916B6A8B5F8D]

向作者/读者索取更多资源

Multidrug-resistant microbial infections and the scarcity of new antibiotics pose a serious threat to global health security. In this study, we found that a combination of a frog-skin antimicrobial peptide, Esc(1-21), and colistin exhibited synergistic effects against colistin-resistant Acinetobacter baumannii clinical isolates, suggesting a potential clinical application of this combination therapy.
Multidrug-resistant microbial infections and the scarce availability of new antibiotics capable of eradicating them are posing a serious problem to global health security. Among the microorganisms that easily acquire resistance to antibiotics and that are the etiological cause of severe infections, there is Acinetobacter baumannii. Carbapenems are the principal agents used to treat A. baumannii infections. However, when strains develop resistance to this class of antibiotics, colistin is considered one of the last-resort drugs. However, the appearance of resistance to colistin also makes treatment of the Acinetobacter infections very difficult. Antimicrobial peptides (AMP) from the innate immunity hold promise as new alternative antibiotics due to their multiple biological properties. In this study, we characterized the activity and the membrane-perturbing mechanism of bactericidal action of a derivative of a frog-skin AMP, namely Esc(1-21), when used alone or in combination with colistin against multidrug-resistant A. baumannii clinical isolates. We found that the mixture of the two compounds had a synergistic effect in inhibiting the growth and killing of all of the tested strains. When combined at dosages below the minimal inhibitory concentration, the two drugs were also able to slow down the microbial growth and to potentiate the membrane-perturbing effect. To the best of our knowledge, this is the first report showing a synergistic effect between AMPs, i.e., Esc(1-21), and colistin against colistin-resistant A. baumannii clinical isolates, highlighting the potential clinical application of such combinational therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据